How is HRSA changing 340B drug diversion oversight for specialty pharmacies in 2026?

In 2026, HRSA has expanded 340B diversion oversight to include shipment verification, patient definition, and contract pharmacy controls across the specialty drug supply chain. Auditors now expect covered entities to document shipment paths, verify contract links on the fill date, and prove patient encounters within their EHR systems to avoid diversion findings.